A decade ago, federal officials drafted a plan to discourage Medicare Advantage health insurers from overcharging the government by billions of dollars — only to abruptly back off amid an “uproar” from the industry, newly released court filings show.
Pfizer targeted by activist, following post-pandemic stumbles — reports
The activist investor Starboard Value has taken a stake in Pfizer, according to media reports, following the drugmaker’s months of lackluster results as it came